CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 2,469 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,497 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,041 shares (option exercise)
- 4 Open-market sale VP of Clinical Development sold 22,149 shares at an average $8.88 ($196,664)
- 4 Exercise or conversion SVP Bus. & Corp. Development acquired 3,085 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 20,576 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
- 4 Exercise or conversion VP of Clinical Development acquired 3,085 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,543 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 19 · 370 filings